Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.9300
+0.0050 (0.54%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Milestone Scientific Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Milestone Scientific stock has a target of 1.25, which predicts an increase of 34.41% from the current stock price of 0.93.
Analyst Consensus: Buy
* Price targets were last updated on Nov 20, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Milestone Scientific is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|
Strong Buy | 0 | 0 | 0 |
Buy | 1 | 1 | 1 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Benchmark | Benchmark | Buy Reiterates $1.25 | Buy | Reiterates | $1.25 | +34.41% | Nov 20, 2024 |
Benchmark | Benchmark | Buy Initiates $1.25 | Buy | Initiates | $1.25 | +34.41% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
11.15M
from 8.63M
Increased by 29.14%
Revenue Next Year
13.43M
from 11.15M
Increased by 20.48%
EPS This Year
-0.05
from -0.06
EPS Next Year
-0.04
from -0.05
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | 11.5M | 13.8M |
Avg | 11.1M | 13.4M |
Low | 10.7M | 12.9M |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | 33.3% | 24.0% |
Avg | 29.1% | 20.5% |
Low | 23.8% | 15.8% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.04 | -0.04 |
Avg | -0.05 | -0.04 |
Low | -0.05 | -0.04 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.